DNA major and minor grooves

The DNA major and minor grooves are fundamental structural features of the B-DNA double helix, created by the specific orientation of the sugar-phosphate backbones relative to the base pairs (Nelson & Cox, 2017). The major groove is wide and deep, offering a complex pattern of chemical signatures that allow sequence-specific recognition by proteins such as transcription factors and restriction enzymes (Rohs et al., 2009). The minor groove is narrower and shallower, serving as the primary binding site for a variety of small-molecule therapeutic agents, including minor groove binders and certain alkylating agents (Neidle, 2001). These grooves are essential for the regulation of gene expression, DNA replication, and repair, as they facilitate the necessary protein-DNA interactions. In clinical practice, drugs targeting these grooves, such as trabectedin and doxorubicin, are widely used to treat various cancers by inhibiting cellular proliferation and inducing apoptosis (D'Incalci & Galmarini, 2010). Additionally, some antimicrobial drugs target the minor groove to disrupt the genomes of bacteria and protozoa. However, because these structural features are present in all genomic DNA, drugs targeting them often exhibit significant genotoxicity and other off-target effects (Pommier, 2006).

Other names

DNA groovesMajor groove of DNAMinor groove of DNADNA binding grooves

Drugs targeting the DNA grooves function by binding non-covalently to the minor groove, intercalating between base pairs with side chains extending into the grooves, or forming covalent adducts. These interactions disrupt the binding of transcription factors and the progression of replication and transcription machinery, leading to cell cycle arrest and apoptosis (Neidle, 2001; D'Incalci & Galmarini, 2010).